Cargando…
Correlates of protection for rotavirus vaccines: Possible alternative trial endpoints, opportunities, and challenges
Rotavirus (RV) is a major vaccine-preventable killer of young children worldwide. Two RV vaccines are globally commercially available and other vaccines are in different stages of development. Due to the absence of a suitable correlate of protection (CoP), all RV vaccine efficacy trials have had cli...
Autores principales: | Angel, Juana, Steele, A Duncan, Franco, Manuel A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514048/ https://www.ncbi.nlm.nih.gov/pubmed/25483685 http://dx.doi.org/10.4161/hv.34361 |
Ejemplares similares
-
Anti-rotavirus antibody measurement in a rotavirus vaccine trial: Choice of vaccine antigen in immunoassays does matter
por: Wang, Xiaoqian, et al.
Publicado: (2023) -
Impact of rotavirus vaccine introduction in Abidjan, Côte d’Ivoire
por: Britoh Mlan, Alice, et al.
Publicado: (2023) -
Immunogenicity of inactivated rotavirus in rhesus monkey, and assessment of immunologic mechanisms
por: Zhou, Yan, et al.
Publicado: (2023) -
Parental preferences for rotavirus vaccination for their children under 5 years old in China: A discrete choice experiment
por: Ma, Wenwen, et al.
Publicado: (2023) -
Cost-effectiveness analysis measuring the total costs against the health benefits of three different rotavirus vaccines for Mexico
por: Gomez, Jorge, et al.
Publicado: (2023)